Business Context and Reporting Period
Company: Flotek Industries, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 2, 2022
Context: The Company entered into a series of material definitive agreements on February 2, 2022, including a private placement of convertible notes, a long-term chemical supply agreement, and a master transaction agreement involving board representation.
Key Financial Metrics and Agreements
- Capital Raised: Approximately $21.2 million in principal amount of 10% convertible PIK (Payment-in-Kind) notes.
- Debt Structure:
- Interest Rate: 10% per annum, payable in incremental Notes or Pre-Funded Warrants.
- Maturity Date: February 2, 2023 (12 months from closing).
- Conversion Price: $1.088125 per share.
- Mandatory Conversion: Notes are mandatorily converted into Common Stock at maturity or upon a change of control at the lesser of the Conversion Price or $0.8705 per share.
- Revenue Commitment: A three-year Chemical Products Supply Agreement with ProFrac Services, LLC, effective April 1, 2022. ProFrac is obligated to purchase a minimum of the greater of a baseline amount or 33% of its requirements.
- Liquidity Use: Proceeds from the offering are designated for liquidity and general corporate purposes.
Material Changes and Strategic Transactions
The filing details a significant shift in capital structure and operational partnerships:
- Private Placement: Issuance of $21.2 million in convertible notes to institutional investors. This includes $10 million in notes issued to ProFrac Holdings in consideration for the Supply Agreement, with the remainder purchased in cash.
- Board Representation: Under the Master Transaction Agreement, ProFrac Holdings was granted the right to designate two designees to serve on the Company's board of directors.
- Registration Rights: The Company agreed to file a shelf registration statement within 120 days to cover the resale of shares issuable upon conversion of the Notes.
- Penalty Clauses: If ProFrac fails to meet minimum purchase obligations under the Supply Agreement, it must pay liquidated damages equal to 25% of the shortfall for that year.
Guidance, Risks, and Contingencies
- Dilution Risk: The Notes are convertible into Common Stock, potentially diluting existing shareholders. Mandatory conversion occurs at maturity or change of control.
- Forced Conversion Trigger: The Company may force conversion if the 20-trading day volume-weighted average trading price of the Common Stock equals or exceeds the greater of $2.50 or $1.741 for 20 trading days during a 30-day period.
- Operational Contingency: Future revenue stability is partially tied to ProFrac's ability to meet the minimum purchase thresholds outlined in the Supply Agreement.
- Management Commentary: The filing does not provide specific forward-looking financial guidance or earnings projections beyond the terms of the agreements.
Key Facts for Investor Verification
- Verify the exact number of shares issuable upon conversion of the $21.2 million in Notes at the current Conversion Price of $1.088125.
- Confirm the status of the Shelf Registration Statement filing, which is required within 120 days of February 2, 2022.
- Monitor the Company's cash burn rate and liquidity position, as the interest on the Notes is paid in-kind (additional debt/equity) rather than cash.
- Review the specific baseline calculation for ProFrac's minimum purchase obligation to assess the certainty of the committed revenue.
- Check for any subsequent filings regarding the appointment of the two ProFrac designees to the Board of Directors.